Referral: Ocaliva, obeticholic acid, Article 20 procedures, Procedure started, 10/11/2023
Opinion/decision on a Paediatric investigation plan (PIP): Inclacumab, decision type: , therapeutic area: , PIP number: P/0545/2022
Opinion/decision on a Paediatric investigation plan (PIP): Treprostinil (palmitil), decision type: , therapeutic area: , PIP number: P/0525/2022
Opinion/decision on a Paediatric investigation plan (PIP): Jakavi,Ruxolitinib (phosphate), decision type: , therapeutic area: , PIP number: P/0486/2022
Summary of opinion: Talzenna,talazoparib, 09/11/2023, Positive
Summary of opinion: Evkeeza,evinacumab, 09/11/2023, Positive
Summary of opinion: Jardiance,empagliflozin, 09/11/2023, Positive
Summary of opinion: Rimmyrah,ranibizumab, 09/11/2023, Positive
Summary of opinion: Spexotras,trametinib, 09/11/2023, Positive
Opinion/decision on a Paediatric investigation plan (PIP): Nipocalimab, decision type: , therapeutic area: , PIP number: P/0509/2022